Key facts
- It has raised $1.3M; the latest was Seed Round ($1.3M) in Dec 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Cartanova
- ·The full record, as it builds
Funding rounds
No funding rounds for Cartanova are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cartanova
Developer of AI driven healthcare systems intended to support sustainable healthcare systems led by medical institutions and public health agencies. The company's platform integrates infectious disease, clinical, microbiological and antimicrobial resistance data within a structured ontology, automates real time monitoring of resistance trends and infection patterns, generates evidence based treatment recommendations with transparent rationale and visualizations, incorporates clinician feedback for continuous refinement, and supports secure interoperability and scalable infrastructure, enabling healthcare and public health stakeholders to access actionable intelligence that enhances decision making, improves patient outcomes, and strengthens system resilience.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2025
- Website
- cartanova.jp/
- Ownership
- Privately Held (backing)
Cartanova doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cartanova shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cartanova in its N-PORT filings yet. We sweep new filings monthly.